These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. General pharmacological profile of the new cognition-enhancing agent nefiracetam. Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090 [TBL] [Abstract][Full Text] [Related]
24. Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse. Micucci M; Aldini R; Cevenini M; Colliva C; Spinozzi S; Roda G; Montagnani M; Camborata C; Camarda L; Chiarini A; Mazzella G; Budriesi R PLoS One; 2013; 8(11):e80925. PubMed ID: 24260512 [TBL] [Abstract][Full Text] [Related]
25. Determination of fenoverine, a modulator of smooth muscle motility, in capsules and in human plasma: application to dosage form stability and a pilot study in humans. Hu OY; Chen PH; Fang YJ; Tang HS; Pao LH; Kwok KM; King ML J Pharm Sci; 1992 Jan; 81(1):91-3. PubMed ID: 1619577 [TBL] [Abstract][Full Text] [Related]
26. [Aprotinin and the cardiac, intestinal and uterine musculature. Experimental studies in vitro]. Lampa E; Russo G; Tartur A; Scognamiglio S; Sannino A; Scafuro A Arch Sci Med (Torino); 1978; 135(2):233-40. PubMed ID: 567467 [TBL] [Abstract][Full Text] [Related]
27. [Experimental analysis of the effects of PGE2 on uterine, intestinal and cardiac musculature and on striated muscle]. Lampa E; Rosatti F; Imperatore A; Magliulo S; Giasi M; Spaziante G; Di Mezza G; Marmo E Arch Ostet Ginecol; 1979; 84(3-4):151-84. PubMed ID: 317990 [No Abstract] [Full Text] [Related]
28. Effects of 1,3,5-trihydroxybenzene and 2,4,6-trihydroxy-1-propiophenone on the smooth muscle organs. Inoue S Jpn J Pharmacol; 1969 Jun; 19(2):224-33. PubMed ID: 5308827 [No Abstract] [Full Text] [Related]
29. [Effects of the diethylaminoethyl ester of monoethylic phenylethylmalonate on intestinal smooth muscle of the rat and mouse in vivo]. de Caro G; Improta G; Maggi L Boll Soc Ital Biol Sper; 1975 Feb; 51(3):127-33. PubMed ID: 1148047 [No Abstract] [Full Text] [Related]
30. Action of carbenicillin on smooth muscles. Dumitrescu S; Nechifor M Rev Med Chir Soc Med Nat Iasi; 1982; 86(4):661-4. PubMed ID: 6892067 [No Abstract] [Full Text] [Related]
31. [Spasmolytic and antispasmodic effect of streptomycin on smooth muscles]. Altinkurt O Turk Hij Tecr Biyol Derg (1961); 1968; 28(2):114-38. PubMed ID: 5733771 [No Abstract] [Full Text] [Related]
33. Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation. Camarri E Curr Med Res Opin; 1986; 10(1):52-7. PubMed ID: 3516580 [TBL] [Abstract][Full Text] [Related]
34. The effect of essential oils from the Bulgarian flora upon isolated smooth musculature of inner organs. Kantarev N; Peicev P Folia Med (Plovdiv); 1977; 19(1):41-5. PubMed ID: 98411 [No Abstract] [Full Text] [Related]
35. Uperolein and other active peptides in the skin of the Australian leptodactylid frogs Uperoleia and Taudactylus. Erspamer V; Negri L; Erspamer GF; Endean R Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(1):41-54. PubMed ID: 1186916 [TBL] [Abstract][Full Text] [Related]
37. Research into individual predisposition to develop acute rhabdomyolysis attributed to fenoverine. Jouglard J; Kozak-Ribbens G; de Haro L; Cozzone PJ Hum Exp Toxicol; 1996 Oct; 15(10):815-20. PubMed ID: 8906430 [TBL] [Abstract][Full Text] [Related]
38. The incidence, risk factors, and clinical outcomes of rhabdomyolysis associated with fenoverine prescription: a retrospective study in South Korea (1999-2014). Cho J; Na J; Bae E; Lee TW; Jang HN; Cho HS; Chang SH; Park DJ BMC Pharmacol Toxicol; 2020 Apr; 21(1):30. PubMed ID: 32334639 [TBL] [Abstract][Full Text] [Related]
39. [Comparative studies with atropine, papaverine, and 1-(3, 4-dimethoxy), 4-diphenyl-1-dimethylaminobutane on a new method for the evaluation of spasmolytics on rat uterus]. ENGELHORN R; SCHMIDT L Arzneimittelforschung; 1956 Aug; 6(8):454-7. PubMed ID: 13373642 [No Abstract] [Full Text] [Related]
40. [The inhibitory effect of pethidine on the intestinal muscle and its mechanism]. Yu YQ; Ma L; Mao LG Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):79-80. PubMed ID: 21186586 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]